Circulating endothelial progenitor cells: a new approach to anti-aging medicine?
- PMID: 20003528
- PMCID: PMC2804590
- DOI: 10.1186/1479-5876-7-106
Circulating endothelial progenitor cells: a new approach to anti-aging medicine?
Abstract
Endothelial dysfunction is associated with major causes of morbidity and mortality, as well as numerous age-related conditions. The possibility of preserving or even rejuvenating endothelial function offers a potent means of preventing/treating some of the most fearful aspects of aging such as loss of mental, cardiovascular, and sexual function.Endothelial precursor cells (EPC) provide a continual source of replenishment for damaged or senescent blood vessels. In this review we discuss the biological relevance of circulating EPC in a variety of pathologies in order to build the case that these cells act as an endogenous mechanism of regeneration. Factors controlling EPC mobilization, migration, and function, as well as therapeutic interventions based on mobilization of EPC will be reviewed. We conclude by discussing several clinically-relevant approaches to EPC mobilization and provide preliminary data on a food supplement, Stem-Kine, which enhanced EPC mobilization in human subjects.
Figures

References
-
- Provis JM, Penfold PL, Cornish EE, Sandercoe TM, Madigan MC. Anatomy and development of the macula: specialisation and the vulnerability to macular degeneration. Clin Exp Optom. 2005;88:269–281. - PubMed
-
- Izikki M, Fadel E, Humbert M, Tu L, Zadigue P, Dartevelle P, Simonneau G, Adnot S, Maitre B, Raffestin B, Eddahibi S. Role for dysregulated endothelium- derived FGF2 signaling in progression of pulmonary hypertension. Rev Mal Respir. 2008;25:1192.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical